Daniel C. Javitt, 10% Owner at NRX Pharmaceuticals, Inc. (NRXP), sold 891,424 shares at $0.65 ($608K) on 2022-06-07, disclosed to the SEC on 2022-06-07.
Open-market sale of $608k NRXP by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.70 | 243,596 | $171K | 28.0% |
| 2 | $0.70 | 243,596 | $171K | 28.0% |
| 3 | $0.67 | 115,657 | $77K | 12.7% |
| 4 | $0.67 | 115,657 | $77K | 12.7% |
| 5 | $0.65 | 86,459 | $56K | 9.2% |
| 6 | $0.65 | 86,459 |
| $56K |
| 9.2% |
| Total | $0.68 avg | 891,424 | $608K | 100% |
| Filing → |
| NRXP | SELL | 2022-11-15 | $50K | — | Filing → |
| NRXP | SELL | 2022-08-02 | $1.6M | — | Filing → |